Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
Overton ET, Kang M, Peters MG, Umbleja T, Alston-Smith BL, Bastow B, Demarco-Shaw D, Koziel MJ, Mong-Kryspin L, Sprenger HL, Yu JY, Aberg JA. Overton ET, et al. Among authors: umbleja t. Vaccine. 2010 Aug 2;28(34):5597-604. doi: 10.1016/j.vaccine.2010.06.030. Epub 2010 Jun 23. Vaccine. 2010. PMID: 20600512 Free PMC article. Clinical Trial.
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).
Sherman KE, Andersen JW, Butt AA, Umbleja T, Alston B, Koziel MJ, Peters MG, Sulkowski M, Goodman ZD, Chung RT; AIDS Clinical Trials Group A5178 Study Team. Sherman KE, et al. Among authors: umbleja t. J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):597-605. doi: 10.1097/QAI.0b013e3181f6d916. J Acquir Immune Defic Syndr. 2010. PMID: 20921898 Free PMC article. Clinical Trial.
Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.
Anthony DD, Umbleja T, Aberg JA, Kang M, Medvik K, Lederman MM, Peters MG, Koziel MJ, Overton ET. Anthony DD, et al. Among authors: umbleja t. Vaccine. 2011 Apr 27;29(19):3558-63. doi: 10.1016/j.vaccine.2011.02.092. Epub 2011 Mar 11. Vaccine. 2011. PMID: 21397720 Free PMC article. Clinical Trial.
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.
Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters MG. Amorosa VK, et al. Among authors: umbleja t. HIV Clin Trials. 2013 Nov-Dec;14(6):274-83. doi: 10.1310/hct1406-274. HIV Clin Trials. 2013. PMID: 24334180 Free PMC article. Clinical Trial.
Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin.
Petersen T, Lee YJ, Osinusi A, Amorosa VK, Wang C, Kang M, Matining R, Zhang X, Dou D, Umbleja T, Kottilil S, Peters MG. Petersen T, et al. Among authors: umbleja t. AIDS Res Hum Retroviruses. 2016 Jul;32(7):660-7. doi: 10.1089/aid.2015.0236. Epub 2016 Mar 14. AIDS Res Hum Retroviruses. 2016. PMID: 26974581 Free PMC article. Clinical Trial.
PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.
Sherman KE, Rouster SD, Kang M, Umbleja T, Sterling R, Butt AA; ACTG 5294 BIRTH Study Team. Sherman KE, et al. Among authors: umbleja t. Dig Dis Sci. 2018 Nov;63(11):2969-2974. doi: 10.1007/s10620-018-5278-y. Epub 2018 Sep 14. Dig Dis Sci. 2018. PMID: 30218427 Free PMC article. Clinical Trial.
37 results